Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Sarcopenia - Overview
Sarcopenia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Sarcopenia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Sarcopenia - Companies Involved in Therapeutics Development
AAVogen Inc
Armgo Pharma Inc
Bioleaders Corp
Biophytis SA
Dystrogen Therapeutics SA
Elevian Inc
Faraday Pharmaceuticals Inc
Gerologix Inc
Helixmith Co Ltd
Keren Therapeutics
MYOS RENS Technology Inc
Neurotune AG
Oncocross Co Ltd
OPKO Health Inc
PhaseBio Pharmaceuticals Inc
Rejuvete Biomed NV
Ridgeline Therapeutics LLC
ST Pharm Co Ltd
Teijin Pharma Ltd
Vibe Pharmaceuticals LLC
Sarcopenia - Drug Profiles
ARM-210 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AVGN-7 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BIO-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Sarcopenia - Dormant Projects
Sarcopenia - Discontinued Products
Sarcopenia - Product Development Milestones
Featured News & Press Releases
Appendix



List of Figures


Number of Products under Development for Sarcopenia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Sarcopenia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Sarcopenia - Pipeline by AAVogen Inc, H2 2020
Sarcopenia - Pipeline by Armgo Pharma Inc, H2 2020
Sarcopenia - Pipeline by Bioleaders Corp, H2 2020
Sarcopenia - Pipeline by Biophytis SA, H2 2020
Sarcopenia - Pipeline by Dystrogen Therapeutics SA, H2 2020
Sarcopenia - Pipeline by Elevian Inc, H2 2020
Sarcopenia - Pipeline by Faraday Pharmaceuticals Inc, H2 2020
Sarcopenia - Pipeline by Gerologix Inc, H2 2020
Sarcopenia - Pipeline by Helixmith Co Ltd, H2 2020
Sarcopenia - Pipeline by Keren Therapeutics, H2 2020
Sarcopenia - Pipeline by MYOS RENS Technology Inc, H2 2020
Sarcopenia - Pipeline by Neurotune AG, H2 2020
Sarcopenia - Pipeline by Oncocross Co Ltd, H2 2020
Sarcopenia - Pipeline by OPKO Health Inc, H2 2020
Sarcopenia - Pipeline by PhaseBio Pharmaceuticals Inc, H2 2020
Sarcopenia - Pipeline by Rejuvenate Biomed NV, H2 2020
Sarcopenia - Pipeline by Ridgeline Therapeutics LLC, H2 2020
Sarcopenia - Pipeline by ST Pharm Co Ltd, H2 2020
Sarcopenia - Pipeline by Teijin Pharma Ltd, H2 2020
Sarcopenia - Pipeline by Vibe Pharmaceuticals LLC, H2 2020
Sarcopenia - Dormant Projects, H2 2020
Sarcopenia - Dormant Projects, H2 2020 (Contd..1), H2 2020
Sarcopenia - Discontinued Products, H2 2020